These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR. Fricker AC; Mok MH; de la Flor R; Shah AJ; Woolley M; Dawson LA; Kew JN Neuropharmacology; 2009; 56(6-7):1060-7. PubMed ID: 19285517 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation. Thomas AG; Olkowski JL; Slusher BS Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia. Cai Z; Lin S; Rhodes PG Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells. Bruno V; Wroblewska B; Wroblewski JT; Fiore L; Nicoletti F Neuroscience; 1998 Aug; 85(3):751-7. PubMed ID: 9639269 [TBL] [Abstract][Full Text] [Related]
12. Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction. Walder KK; Ryan SB; Bzdega T; Olszewski RT; Neale JH; Lindgren CA Eur J Neurosci; 2013 Jan; 37(1):118-29. PubMed ID: 23134476 [TBL] [Abstract][Full Text] [Related]
13. N-acetylaspartylglutamate and beta-NAAG protect against injury induced by NMDA and hypoxia in primary spinal cord cultures. Yourick DL; Koenig ML; Durden AV; Long JB Brain Res; 2003 Nov; 991(1-2):56-64. PubMed ID: 14575876 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures. Prézeau L; Carrette J; Helpap B; Curry K; Pin JP; Bockaert J Mol Pharmacol; 1994 Apr; 45(4):570-7. PubMed ID: 8183235 [TBL] [Abstract][Full Text] [Related]
16. Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain. Shave E; Pliss L; Lawrance ML; FitzGibbon T; Stastny F; Balcar VJ Neurochem Int; 2001 Jan; 38(1):53-62. PubMed ID: 10913688 [TBL] [Abstract][Full Text] [Related]
17. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats. Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276 [TBL] [Abstract][Full Text] [Related]
18. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors. Urazaev AK; Grossfeld RM; Lieberman EM J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619 [TBL] [Abstract][Full Text] [Related]
19. N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin. Thomas AG; Vornov JJ; Olkowski JL; Merion AT; Slusher BS J Pharmacol Exp Ther; 2000 Oct; 295(1):16-22. PubMed ID: 10991955 [TBL] [Abstract][Full Text] [Related]